Prolactin receptor expression in the developing human prostate and in hyperplastic, dysplastic, and neoplastic lesions

被引:73
作者
Leav, I
Merk, FB
Lee, KF
Loda, M
Mandoki, M
McNeal, JE
Ho, SM [1 ]
机构
[1] Tufts Univ, Dept Biol, Medford, MA 02155 USA
[2] Tufts Univ, Sch Med, Dept Pathol, Boston, MA 02111 USA
[3] Tufts Univ, Sch Vet Med, Boston, MA 02111 USA
[4] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Pathol, Boston, MA USA
[5] Stanford Univ, Med Ctr, Dept Urol, Stanford, CA 94305 USA
关键词
D O I
10.1016/S0002-9440(10)65333-3
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
In situ hybridization and immunohistochemistry were used to localize and compare the expression of the long form of the human prolactin receptor in fetal, prepubertal, and adult prostate. Results were then compared with hyperplastic, dysplastic, and neoplastic lesions, Both receptor message and protein were predominately localized in epithelial cells of the fetal, neonatal, prepubertal, and normal adult prostate. In hyperplastic lesions the expression of the receptor was unchanged with respect to normal epithelial cells. Irrespective of grade, markedly enhanced expression of the receptor was evident in dysplastic lesions. In lower Gleason grade carcinomas the intensity of receptor signal at the message and protein levels approximated that found in normal prostatic epithelium However, In foci within higher grade cancers, receptor expression appeared diminished. Results from our study suggest that prolactin action plays a role in the development and maintenance of the human prostate and may also participate In early neoplastic transformation of the gland. Diminution of receptor expression in high grade neoplasms could reflect the emergence of a population of cells that are no longer responsive to the peptide hormone.
引用
收藏
页码:863 / 870
页数:8
相关论文
共 43 条
[1]   CHARACTERIZATION OF A MONOCLONAL-ANTIBODY AGAINST HUMAN PROLACTIN RECEPTORS [J].
BANERJEE, R ;
GINSBURG, E ;
VONDERHAAR, BK .
INTERNATIONAL JOURNAL OF CANCER, 1993, 55 (05) :712-721
[2]  
BARTKE A, 1977, P367
[3]   Extrapituitary prolactin: Distribution, regulation, functions, and clinical aspects [J].
BenJonathan, N ;
Mershon, JL ;
Allen, DL ;
Steinmetz, RW .
ENDOCRINE REVIEWS, 1996, 17 (06) :639-669
[4]   Prolactin (PRL) and its receptor: Actions, signal transduction pathways and phenotypes observed in PRL receptor knockout mice [J].
Bole-Feysot, C ;
Goffin, V ;
Edery, M ;
Binart, N ;
Kelly, PA .
ENDOCRINE REVIEWS, 1998, 19 (03) :225-268
[5]   MULTIDIRECTIONAL DIFFERENTIATION IN THE NORMAL, HYPERPLASTIC, AND NEOPLASTIC HUMAN PROSTATE - SIMULTANEOUS DEMONSTRATION OF CELL-SPECIFIC EPITHELIAL MARKERS [J].
BONKHOFF, H ;
STEIN, U ;
REMBERGER, K .
HUMAN PATHOLOGY, 1994, 25 (01) :42-46
[6]  
BOSTWICK DG, 1995, CANCER-AM CANCER SOC, V75, P1823, DOI 10.1002/1097-0142(19950401)75:7+<1823::AID-CNCR2820751612>3.0.CO
[7]  
2-7
[8]   IDENTIFICATION OF A CDNA-ENCODING A LONG FORM OF PROLACTIN RECEPTOR IN HUMAN HEPATOMA AND BREAST-CANCER CELLS [J].
BOUTIN, JM ;
EDERY, M ;
SHIROTA, M ;
JOLICOEUR, C ;
LESUEUR, L ;
ALI, S ;
GOULD, D ;
DJIANE, J ;
KELLY, PA .
MOLECULAR ENDOCRINOLOGY, 1989, 3 (09) :1455-1461
[9]   IDENTIFICATION OF PROLACTIN RECEPTORS IN HEPATIC NUCLEI [J].
BUCKLEY, AR ;
MONTGOMERY, DW ;
HENDRIX, MJC ;
ZUKOSKI, CF ;
PUTNAM, CW .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1992, 296 (01) :198-206
[10]   Prolactin as an Autocrine/Paracrine Factor in Breast Tissue [J].
Clevenger, Charles V. ;
Plank, Tracey L. .
JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA, 1997, 2 (01) :59-68